.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Deloitte
Chubb
Dow
Argus Health
Covington
McKesson
Moodys
Novartis

Generated: September 26, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Contrast media comprising a non-ionic contrast agent and sodium ions
Abstract:The invention relates to improved contrast media containing non-ionic contrast agents, e.g. non-ionic iodinated X-ray contrast agents, the improvement being achieved by incorporation of sodium at 20-60 mM/l.
Inventor(s): Almen; Torsten (Malmo, SE), B.ANG..ANG.th; Laars (Malmo, SE), Oksendal; Audun (Oslo, NO)
Assignee: Nycomed Imaging AS (Oslo, NO)
Application Number:08/156,998
Patent Claims: 1. A contrast medium comprising a non-ionic contrast agent in a physiologically tolerable aqueous carrier medium characterized in that said medium has a sodium ion concentration of from 26 up to 26 mM, whereby a beneficial balance between the lowering of red blood cell aggregate formation, lowering of echinocyte formation, increasing of rouleaux formation, lowering of contractile force reduction and lowering of the occurrence of ventricular fibrillation is achieved.

2. A medium as claimed in claim 1 wherein said sodium ion concentration is in the range 27 to 30 mM.

3. A medium as claimed in claim 1 wherein the contrast agent is a ratio 3 or 6 iodinated X-ray contrast agent.

4. A medium as claimed in claim 3 wherein the contrast agent is an iodinated X-ray contrast agent selected from the group consisting of metrizamide, iopromide, iopentol, iopamidol, iohexol, loversol, iotrolan and iodixanol.

5. A medium as claimed in claim 3 wherein the contrast agent is present at a concentration of at least 100 mg I/ml.

6. A medium as claimed in claim 1 having an osmolality of less than 1 osm/kg H.sub.2 O.

7. A medium as claimed in claim 1 further comprising physiologically tolerable cations.

8. A method of cardiac imaging of the human or non-human animal body, which method comprises administering to said body a contrast medium as claimed in claim 1 and generating an image of at least a part of the cardiac region of said body.

9. A medium as claimed in claim 1 wherein said agent is an iodinated X-ray contrast agent.

10. A medium as claimed in claim 7 wherein said cations are selected from the group consisting of chloride, phosphate, hydrogen carbonate and a mixture thereof.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Farmers Insurance
Fish and Richardson
Cipla
McKesson
Accenture
US Army
Mallinckrodt
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot